BeiGene, (NASDAQ:BGNE, HKEX: 06160, SSE: 688235)), a global biotechnology, today announced BRUKINSA (zanubrutinib) has been approved in Brazil for the treatment of adult patients with Waldenström’s
Apple Inc (NASDAQ:AAPL) supplier Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) is looking for local sources of neon gas after Vladimir Putin's war in Ukraine